Anthem Biosciences confirms no encumbrance on promoter shares in FY26

1 min read Updated on 17 Jun 2026, 01:11 AM

Reviewed by

Anirudha BScanX News Team

AI Summary

Anthem Biosciences Ltd confirmed that its promoter group, led by Ishaan Bhardwaj, did not create any encumbrance on shares during FY26. The disclosure was made to stock exchanges under SEBI takeover regulations. The promoter group includes eight members.

*this image is generated using AI for illustrative purposes only.

Anthem Biosciences Ltd has confirmed that its promoter group did not encumber any shares during the financial year ended March 31, 2026. The disclosure, submitted to BSE and NSE, assures stakeholders that no shares held by promoters directly or indirectly were pledged or otherwise charged during this period.

The declaration was made by Ishaan Bhardwaj on behalf of the promoter and promoter group pursuant to Regulation 31(4) and 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms compliance with regulatory requirements regarding the disclosure of share encumbrances by substantial shareholders.

The promoter group comprises eight members, including Ishaan Bhardwaj. The list of individuals forming the promoter group was provided as Annexure A to the regulatory filing.

Promoter Group Details

Name of the members of Promoter Group
Ishaan Bhardwaj
Kashmiira Nayar
Madhavi Jayanti
Ajay Bhardwaj
Arti Bhardwaj
Raman Nayar
Pramila Raman Nayar
Nischel Rye Nayar
Rahul Vyan Nayar

The declaration was signed on April 6, 2026, in Bengaluru. A copy of the communication was also forwarded to the Audit Committee of Anthem Biosciences Ltd .

Historical Stock Returns for Anthem Biosciences

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+3.99%	+4.18%	+1.89%	+20.06%	+9.28%	+9.28%

How will the zero-encumbrance status impact investor confidence and institutional interest in Anthem Biosciences?

Does this financial stability indicate potential plans for capital expansion or new R&D investments by the promoter group?

How might this disclosure influence the company's credit rating and borrowing costs in the upcoming fiscal year?

Read Next Article

Anthem Biosciences schedules investor meet on June 10

0 min read Updated on 06 Jun 2026, 08:49 AM

Reviewed by

Anirudha BScanX News Team

Add as a preferred
source on Google

AI Summary

Anthem Biosciences Limited will conduct a plant visit and group meeting with analysts and institutional investors on June 10, 2026, in Bangalore. The physical event will not involve the discussion of any unpublished price-sensitive information (UPSI).

*this image is generated using AI for illustrative purposes only.

Anthem Biosciences Limited will host a plant visit followed by a group meeting with analysts and institutional investors on June 10, 2026. The event is scheduled to take place in Bangalore and will be conducted in physical mode. The company confirmed that no unpublished price-sensitive information (UPSI) will be discussed during the meeting or the plant visit.

The disclosure was made pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that any unforeseen exigency on the part of the company or host may lead to a change in the date or time of the event.